CCM
GMED icon

Channing Capital Management’s Globus Medical GMED Stock Holding History

Channing Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-77,277
Closed -$6.39M – 114
2024
Q4 		$6.39M Sell
77,277
-24,161
-24% -$1.91M 0.17% 98
2024
Q3 		$7.26M Sell
101,438
-3,815
-4% -$269K 0.19% 93
2024
Q2 		$7.21M Sell
105,253
-35,994
-25% -$2.15M 0.2% 88
2024
Q1 		$7.58M Buy
141,247
+7,382
+6% +$397K 0.2% 92
2023
Q4 		$7.13M Buy
133,865
+9,871
+8% +$481K 0.21% 87
2023
Q3 		$6.16M Buy
+123,994
New +$6.93M 0.2% 83

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Channing Capital Management's GMED Position: Q1 2025 in Review

Channing Capital Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 77,277 shares — an estimated $6.39M sold.

Channing Capital Management first reported a position in GMED in Q3 2023 and held it in 6 quarters. The position peaked at $7.58M in Q1 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Channing Capital Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Channing Capital Management sold 77,277 Globus Medical shares in Q1 2025, an estimated $6.39M.
  • Channing Capital Management first reported a position in Globus Medical in Q3 2023 and held it in 6 quarters.
  • Channing Capital Management's Globus Medical position peaked at $7.58M in Q1 2024.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Channing Capital Management's 13F filing for Q1 2025, filed 14 May 2025.